Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** 4-{4-[3-(2,4-dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid is a synthetic small molecule with the molecular formula C20H20Cl2N2O5 and a molecular weight of approximately 439.29 g/mol[1][2][5]. It is structurally related to phenoxy butyric acids and contains both dichlorobenzoyl and ureido functional groups. The compound has been referenced in chemical databases such as PubChem (CID:5326886), ChemSpider (ID:4484178), and DrugBank[1][5]. Mechanistically or pharmacologically relevant information about its clinical use or therapeutic indication is not available in public drug databases; it appears to be an experimental compound. There are no known brand names or marketed formulations for this substance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-{4-[3-(2,4-dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid.